scholarly article | Q13442814 |
P50 | author | Jianming Tang | Q45997233 |
Beatrice H. Hahn | Q55293537 | ||
Alan S. Perelson | Q55719625 | ||
Etienne Karita | Q72386151 | ||
George M. Shaw | Q78514357 | ||
Paul A Goepfert | Q87472808 | ||
Ruy M. Ribeiro | Q30504775 | ||
P2093 | author name string | Rong Rong | |
Jill Gilmour | |||
Eric Hunter | |||
Cynthia A Derdeyn | |||
Susan A Allen | |||
Daniel T Claiborne | |||
Jessica L Prince | |||
Ling Yue | |||
Cecilia Chui | |||
Katja J Pfafferott | |||
Joshua Baalwa | |||
Emmanuel Cormier | |||
Karen Conrod | |||
Catherine C Dong | |||
P2860 | cites work | HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners | Q46171893 |
HIV evolution: CTL escape mutation and reversion after transmission | Q47211742 | ||
Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission | Q47878972 | ||
Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes | Q48088168 | ||
Elite control of HIV infection: implications for vaccine design | Q56994404 | ||
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load | Q57259602 | ||
Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes | Q72112068 | ||
Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion | Q72624142 | ||
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS | Q73034306 | ||
Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection | Q77386243 | ||
A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects | Q77399464 | ||
Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection | Q80819695 | ||
Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection | Q83862341 | ||
Common genetic variation and the control of HIV-1 in humans | Q21092450 | ||
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection | Q24645815 | ||
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome | Q24648628 | ||
The Antibody Response against HIV-1 | Q27000889 | ||
Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth | Q27676728 | ||
Long-term HIV-1 infection without immunologic progression | Q28242263 | ||
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus | Q28302762 | ||
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection | Q28304764 | ||
Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships | Q28394085 | ||
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load | Q28475652 | ||
Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells | Q28748976 | ||
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation | Q29417018 | ||
Antibody neutralization and escape by HIV-1 | Q29547345 | ||
A whole-genome association study of major determinants for host control of HIV-1 | Q29614891 | ||
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Q29616205 | ||
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
Rapid evolution of the neutralizing antibody response to HIV type 1 infection | Q29618603 | ||
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. | Q29619254 | ||
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
Optimized determination of T cell epitope responses | Q31133720 | ||
Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage | Q33325923 | ||
Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1 | Q33402461 | ||
Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics | Q33429049 | ||
Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways | Q33504599 | ||
HIV-1 transmitting couples have similar viral load set-points in Rakai, Uganda | Q33576652 | ||
Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection | Q33828583 | ||
Immune responses to HIV and SIV in mucosal tissues: 'location, location, location'. | Q33915790 | ||
HIV RNA level in early infection is predicted by viral load in the transmission source | Q33921382 | ||
Impaired replication capacity of acute/early viruses in persons who become HIV controllers | Q33963989 | ||
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. | Q34009945 | ||
Additive contribution of HLA class I alleles in the immune control of HIV-1 infection | Q34120809 | ||
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection | Q34228730 | ||
Impact of MHC class I diversity on immune control of immunodeficiency virus replication | Q34235198 | ||
Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection | Q34295972 | ||
Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia | Q34327190 | ||
Specificity of the autologous neutralizing antibody response | Q34415389 | ||
HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication | Q34448446 | ||
Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. | Q34468117 | ||
The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter | Q34485260 | ||
Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis | Q34499377 | ||
Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1 | Q34648079 | ||
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection | Q37273158 | ||
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection | Q37273195 | ||
Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients | Q37273283 | ||
Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers | Q37442895 | ||
T cell immunity in acute HIV-1 infection. | Q37789345 | ||
HIV-1 replicative fitness in elite controllers | Q37856676 | ||
Phylogenetic evaluation of Kenyan HIV type 1 isolates | Q38558632 | ||
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120 | Q39612212 | ||
Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers | Q40659603 | ||
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes | Q40669542 | ||
Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design | Q41338220 | ||
The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. | Q41531784 | ||
Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. | Q41827503 | ||
HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition | Q41966337 | ||
The rate of immune escape vanishes when multiple immune responses control an HIV infection | Q42277067 | ||
Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers | Q43215260 | ||
Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors. | Q44179257 | ||
Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study | Q44429168 | ||
Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study | Q45743784 | ||
Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors | Q45772545 | ||
The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? | Q45783098 | ||
Elucidating the elite: mechanisms of control in HIV-1 infection | Q35008384 | ||
Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. | Q35076519 | ||
Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection | Q35274776 | ||
Role of donor genital tract HIV-1 diversity in the transmission bottleneck | Q35558621 | ||
Definition of the viral targets of protective HIV-1-specific T cell responses | Q35800157 | ||
Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity | Q35826266 | ||
HIV and SIV CTL escape: implications for vaccine design | Q35852284 | ||
Clade-specific differences between human immunodeficiency virus type 1 clades B and C: diversity and correlations in C3-V4 regions of gp120. | Q35857408 | ||
Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection | Q35947590 | ||
Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape | Q36000736 | ||
Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans | Q36231666 | ||
Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations | Q36238124 | ||
Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. | Q36315572 | ||
Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. | Q36368095 | ||
Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response | Q36399559 | ||
Vertical T cell immunodominance and epitope entropy determine HIV-1 escape | Q36497283 | ||
HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44 | Q36498061 | ||
Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones | Q36532973 | ||
Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection | Q36559632 | ||
Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection | Q36576849 | ||
Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients | Q36639954 | ||
Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques | Q36702206 | ||
Frequent and variable cytotoxic-T-lymphocyte escape-associated fitness costs in the human immunodeficiency virus type 1 subtype B Gag proteins | Q36759719 | ||
Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection | Q36845710 | ||
Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes | Q36845893 | ||
Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies | Q36884458 | ||
Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy | Q36950611 | ||
Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy | Q37033224 | ||
HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. | Q37033250 | ||
Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies | Q37033269 | ||
Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control | Q37054526 | ||
HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703 | Q37081581 | ||
Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. | Q37099792 | ||
Influence of HLA-C expression level on HIV control | Q37200459 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P921 | main subject | HIV transmission | Q49029021 |
P304 | page(s) | e1004565 | |
P577 | publication date | 2015-01-08 | |
P1433 | published in | PLOS Pathogens | Q283209 |
P1476 | title | Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients | |
P478 | volume | 11 |
Q30381208 | A Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1. |
Q47548907 | Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutations. |
Q59356540 | Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection |
Q37221660 | Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults |
Q35697246 | CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV-1 infection: findings from an African cohort with prospective data |
Q89686737 | CD8+ T cells in HIV control, cure and prevention |
Q30381239 | Composite Sequence-Structure Stability Models as Screening Tools for Identifying Vulnerable Targets for HIV Drug and Vaccine Development. |
Q64068820 | Defining Kinetic Properties of HIV-Specific CD8⁺ T-Cell Responses in Acute Infection |
Q37252894 | Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection |
Q36194234 | Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth |
Q33809708 | Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller |
Q58085173 | HIV control: Is getting there the same as staying there? |
Q26765966 | HIV-Host Interactions: Implications for Vaccine Design |
Q35778333 | Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance |
Q92883461 | Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach |
Q35694015 | Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes. |
Q36223864 | New prospects for a preventive HIV-1 vaccine |
Q39735439 | Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells. |
Q40349815 | Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression |
Q37612507 | Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness |
Q26772713 | Role of HLA Adaptation in HIV Evolution |
Q38491191 | Success and failure of the cellular immune response against HIV-1. |
Q40091554 | The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards |
Q30240629 | Understanding the complex evolution of rapidly mutating viruses with deep sequencing: Beyond the analysis of viral diversity |
Q52325888 | Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers. |
Q39400038 | Virus-Host Gene Interactions Define HIV-1 Disease Progression. |
Search more.